Vaccine Funding And Access Key To Pharma Success In Developing World
Vaccine consultant Jacqueline Keith in an interview described promising advances but also challenges to the funding, development, and delivery of vaccines to the neediest populations. The role of public/private partnerships at each stage of the vaccine value chain is critical to assuring win-win outcomes.
You may also be interested in...
Although cancer grabs the spotlight for harnessing the immune system against tumors, other therapeutic areas and modalities are being developed in the shadows. Genocea Biosciences thinks it has a surefire way to identify novel antigens for T-cell vaccines. It hopes to shake up large infectious disease markets, and more.
Ex-Genentech executive Susan Desmond-Hellman soon will leave her position as UCSF chancellor to become CEO of the Gates Foundation. Her move signals the foundation’s ambition to lead in the science and the financing of neglected and tropical diseases, as well as in the global alliances that enable both.
Initiative to build health care infrastructure and create a sales channel for GSK medicines is starting to yield tangible results.